---
schema_version: "secwatch.filing_event.v1"
accession: "0000059478-21-000175"
form_type: "8-K"
ticker: "LLY"
cik: "0000059478"
company_name: "ELI LILLY & Co"
filed_at: "2021-08-17T23:59:59+00:00"
generated_at: "2026-06-29T09:41:23.367109+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lilly restructures leadership; Zulueta retiring, Yuffa to lead International, new Neuroscience & Immunology units

## Summary
- Alfonso Zulueta, President of Lilly International, to retire effective Dec 26, 2021; succeeded by Ilya Yuffa.
- Lilly Bio-Medicines splits into two units: Lilly Neuroscience (led by Anne White) and Lilly Immunology (led by Patrik Jonsson).
- Jake Van Naarden promoted to CEO of Loxo Oncology at Lilly and President of Lilly Oncology, joins executive committee.
- Donanemab (Alzheimer's) BLA submission planned under accelerated approval pathway; tirzepatide (type 2 diabetes) potential launch cited.
- Changes effective Sept 5, 2021; CEO David Ricks cites focus on late-stage pipeline and breakthrough medicines.

## SEC filing metadata
- accession: 0000059478-21-000175
- form_type: 8-K
- ticker: LLY
- cik: 0000059478
- company_name: ELI LILLY & Co
- filed_at: 2021-08-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/59478/000005947821000175/0000059478-21-000175-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/59478/000005947821000175/lly-20210811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000059478-21-000175
- JSON: https://secwatch.observer/filing/0000059478-21-000175.json
- Plain text: https://secwatch.observer/filing/0000059478-21-000175.txt

## Key facts
- Executive change
  Alfonso Zulueta departed as Senior Vice President and President, Lilly International at ELI LILLY & Co.
  - Action: retire
  - Role: Senior Vice President and President, Lilly International
  source text: On August 11, 2021, Alfonso Zulueta, Senior Vice President and President, Lilly International, of Eli Lilly and Company (the “Company”) notified the Board of Directors of the Company of his intent to retire from his position with the Company effective as of December 26, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/59478/000005947821000175/0000059478-21-000175-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.